(Press-News.org) Sickle cell disease is the most common inherited red blood cell disorder in the United States and can lead to health problems including organ dysfunction, acute chest syndrome and strokes over a patient’s lifespan. According to a new study, individuals living with sickle cell disease who experience a delay of more than six months after transferring from pediatric to adult care are twice as likely to be hospitalized compared to those who transition in less than two months.
In the study, Kristen Howell, PhD, assistant professor in the Department of Epidemiology and Biostatistics at the Texas A&M University School of Public Health, and colleagues used data on individuals with sickle cell disease who completed pediatric care at St. Jude Children’s Research Hospital in Memphis between 2012 and 2018. The clinic at St. Jude runs a transition preparation program that starts at age 12 in educating patients on the transition process and introduces them to adult health care facilities at the age of 17. Current guidelines state that individuals with chronic disease should transfer from pediatric care to adult care within six months; however, this had not been studied in a sickle cell population.
Howell and colleagues followed patients from their first adult care visit through the end of 2020 and excluded patients who did not have an adult care appointment after leaving pediatric care. The researchers measured the length of time between the last pediatric visit and first adult appointment and categorized that length as less than two months, two to six months and six months or greater. They also tracked routine outpatient visits, inpatient hospitalizations and emergency department use during the study period. Lastly, the analysis included data on factors like sickle cell disease genotype, patient sex and health insurance type at time of transfer.
The analysis found that around 88 percent of the study participants successfully transferred to adult care within the recommended six-month period, with a median transfer gap of about a month and a half. Howell noted that those who transitioned to adult care within the recommended period had more outpatient visits and less acute care use. In contrast, those who had transfer gaps longer than six months were two times more likely to need hospitalization.
“There are several barriers to transition including challenges in care coordination, insurance coverage, and institutional and practioner bias. Transition programs are designed to help address these barriers,” Howell said. “The goal of this study is to provide evidence to support the transition guidelines of a six-month transfer gap and improve the health of individuals with sickle cell disease as they enter adulthood.”
The researchers suggest that transition programs that include early introductions to adult care, promotion of patient self-efficacy and health literacy education help improve health outcomes.This confirms that a swift transfer — specifically, less than six months — from pediatric to adult care may reduce the use of acute care services in adult care.
END
Study shows timely transition from pediatric to adult care is critical for young adults with sickle cell disease
Waiting more than six months raises likelihood of hospital stay in first two years of adult care
2024-07-15
ELSE PRESS RELEASES FROM THIS DATE:
University of Cincinnati study: Long-term stroke survival improving, but racial disparities remain
2024-07-15
Overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals, according to University of Cincinnati research published online July 15 in Neurology®, the medical journal of the American Academy of Neurology.
UC’s David Robinson, MD, corresponding author on the research, said prior studies had examined short-term stroke outcomes of 30 or 60 days, but this time the team looked at survival rates five years past a person’s stroke.
“This was ...
National Institutes of Health grant could mean progress toward improved outcomes for stroke patients
2024-07-15
The Associate Dean of Research at the University of Tennessee Health Science Center’s College of Nursing has received a two-year, $421,188 grant from the National Institutes of Health (NIH) to improve cognitive screening in people who suffer from a devastating type of stroke called aneurysmal subarachnoid hemorrhage (aSAH).
Professor Ansley Stanfill, PhD, RN, FAAN, has devoted her program of research to improving outcomes for people who survive strokes. Her latest grant aims to determine if an existing screening tool can be used in a new way to assess patients following aSAH and trigger a ...
SfN establishes James L. Roberts Endowed Fund
2024-07-15
Washington, D.C. – The Society for Neuroscience (SfN) has received $128,000 from the estate of James L. Roberts, PhD. With the funds, SfN Council voted to create a new long-term endowed fund, The James L. Roberts Fund, and will use the income from its investments to create and perpetually fund James L. Roberts Trainee Professional Development Awards (TPDAs) beginning at Neuroscience 2024.
“I knew Jimmy Roberts very well. We basically launched neurobiology at Sinai when we co-directed the Fishberg Research Center for Neurobiology at Mount Sinai from 1989–2002,” said incoming SfN President John Morrison. “Jimmy was an outstanding ...
Unlocking the mystery of preexisting drug resistance: New study sheds light on cancer evolution
2024-07-15
CLEVELAND—The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Despite the expectation that resistance-conferring mutations would dwindle in the absence of treatment due to a reduced growth rate, preexisting resistance is pervasive across diseases that evolve—like cancer and pathogens—defying conventional wisdom.
In cancer, it is well known that small numbers of drug-resistant cells likely exist in tumors even before they’re treated. In something of a paradox, before treatment, these mutants have been repeatedly shown to have lower fitness than the surrounding ancestor cells from which they arose. It leads ...
New study reveals critical role of C1q protein in neuronal function and aging
2024-07-15
BOSTON, Mass. (July 15, 2024)—A groundbreaking study conducted at the lab of Beth Stevens, PhD, at Boston Children’s Hospital has revealed that an immune protein impacts neuronal protein synthesis in the aging brain. Previous work from the Stevens lab had uncovered that immune cells in the central nervous system, microglia, help prune synapses in the developing brain by tagging synapses with the immune protein C1q. New research led by Nicole Scott-Hewitt, published in Cell, shows that neurons can also internalize C1q. C1q seems to influence protein production inside neurons by interacting with ribosomal proteins, RNA-binding proteins, and ...
New research demonstrates potential for increasing effectiveness of popular diabetes, weight-loss drugs
2024-07-15
A network of proteins found in the central nervous system could be harnessed to increase the effectiveness and reduce the side effects of popular diabetes and weight-loss drugs, according to new research from the University of Michigan.
The study, appearing today in the Journal of Clinical Investigation, focused on two proteins called melanocortin 3 and melanocortin 4 found primarily on the surface of neurons in the brain that play a central role in regulating feeding behavior and maintaining the body's energy balance.
Melanocortin ...
Understanding the 3D ice-printing process to create micro-scale structures
2024-07-15
Advances in 3D printing have enabled many applications across a variety of disciplines, including medicine, manufacturing, and energy. A range of different materials can be used to print both simple foundations and fine details, allowing for the creation of structures with tailored geometries.
However, creating structures with micro-scale, precise internal voids and channels still poses challenges. Scaffolds used in tissue engineering, for example, must contain a three-dimensional complex network of conduits that mimic the human vasculature. With traditional additive manufacturing, where the material is deposited layer ...
Children’s Hospital of Philadelphia researchers develop antioxidant strategy to address mitochondrial dysfunction caused by SARS-CoV-2 virus
2024-07-15
Philadelphia, July 15, 2024 – Building upon groundbreaking research demonstrating how the SARS-CoV-2 virus disrupts mitochondrial function in multiple organs, researchers from Children’s Hospital of Philadelphia (CHOP) demonstrated that mitochondrially-targeted antioxidants could reduce the effects of the virus while avoiding viral gene mutation resistance, a strategy that may be useful for treating other viruses. The preclinical findings were recently published in the journal Proceedings ...
How climate change is altering the Earth’s rotation
2024-07-15
Climate change is causing the ice masses in Greenland and Antarctica to melt. Water from the polar regions is flowing into the world’s oceans –and especially into the equatorial region. “This means that a shift in mass is taking place, and this is affecting the Earth’s rotation,” explains Benedikt Soja, Professor of Space Geodesy at the Department of Civil, Environmental and Geomatic Engineering at ETH Zurich.
“It’s like when a figure skater does a pirouette, first holding her arms close to her body and then stretching ...
Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma
2024-07-15
“FDG-PET is generally considered as a useful metabolic evaluation tool, while it is also thought to have an emerging role for assessment of systemic therapy response.”
BUFFALO, NY- July 15, 2024 – A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.”
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm and affected ...
LAST 30 PRESS RELEASES:
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
More scrutiny of domestic fishing fleets at ports could help deter illegal fishing
Scientists transform plastic waste into efficient CO2 capture materials
Discovery of North America’s role in Asia’s monsoons offers new insights into climate change
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Researchers discover massive geo-hydrogen source to the west of the Mussau Trench
[Press-News.org] Study shows timely transition from pediatric to adult care is critical for young adults with sickle cell diseaseWaiting more than six months raises likelihood of hospital stay in first two years of adult care